New approaches for managing gastro-oesophageal reflux disease (GORD) are evolving, impacting patient outcomes and surgical practices.

• Potassium-competitive acid blockers show higher healing rates and longer acid suppression than proton pump inhibitors.
• Robotic antireflux surgery yields outcomes comparable to traditional laparoscopic methods.
• Novel endoscopic techniques and devices are under evaluation, offering potential alternatives for patient treatment.

Surgeons should adapt to these advancements to enhance personalized care for GORD patients.

Combining enhanced recovery after surgery (ERAS) nursing with early enteral nutrition significantly improves recovery for gastric cancer patients after radical gastrectomy.

• First flatus occurs 2.45 days vs. 3.84 days; first bowel movement 3.39 vs. 5.61 days.
• Hospital stay reduced: 8.75 days vs. 12.50 days.

This approach also improves nutritional markers and lowers complication rates (6.25% vs. 31.25%).

• Quality of life scores improved across multiple domains.

Postoperative C-reactive protein levels are key indicators for survival outcomes in gastric cancer patients.

• Elevated CRP post-surgery correlates with increased mortality and recurrence risk (HR: 1.51 for OS, HR: 1.44 for RFS).
• CRP peak in the first week after surgery shows strong prognostic value, predicting worse outcomes (HR: 1.80 for OS, HR: 1.63 for RFS).

Incorporating CRP monitoring could enhance patient selection and outcome predictions in surgical practice.

• Optimal timing and thresholds for CRP measurements should be established in future studies.

Higher glycemic variability signals increased mortality risk in gastric surgery patients.

• Each 1% increase in glycemic variability raises 30-day mortality by 15% and 90-day mortality by 14%.
• Critical thresholds identified at glycemic variability levels of 20.24 for 30-day mortality and 33.96 for 90-day mortality.

Monitoring and managing glycemic variability could significantly improve patient outcomes after gastric surgery.

• The predictive model achieving an AUC of 0.83 underscores the clinical relevance of glycemic control in surgical settings.

Endoscopic and surgical interventions significantly enhance outcomes for anastomotic leakage post-esophagectomy.

• Observation group had a 73% fistula closure rate versus 53% in the control group.
• Clinical treatment scores were higher at 3 months (5.67 vs. 4.73) and 6 months (8.33 vs. 6.27) for the observation group.

These findings support early intervention to improve patient quality of life without increasing complication rates.

• Dysphagia scores improved significantly in the observation group, highlighting benefits beyond physical healing.